Warning: Creating default object from empty value in /web/htdocs/www.eamas.net/home/CzetaFrameWork/index.php on line 35
EAMAS - Associazione Europea amici della Sindrome di McCune-Albright

EAMAS - Associazione Europea amici della Sindrome di McCune-Albright

European Association Friends of Mc Cune Albright Syndrome

Scegli la lingua:
IT EN FR DE ES

Contatta EAMAS


Home

Che cos'è EAMAS
Patologie trattate
Esperienze personali
Medici e ospedali
Glossario
Pubblicazioni
Link utili
Novità dell'associazione
Conferenze e simposi
Come finanziare EAMAS

Sponsor dell'anno

Ultimo aggiornamento:
12/12/2019

Best view 1024 x 768
Ottimizzato per IE



 

 

Pubblicazioni

Elenco completo

Elenco completo

PATOLOGIA: LINGUA:  
ARGOMENTO: TESTO:
TITOLOAUTORIEDITOREANNODOSSIERPAGINELINGUA
Autonomous ovarian hyperfunction followed by gonadotropin-dependent puberty in the McCune-Albright syndromeKaufman FR, Costin G, Reid BS,Clin Endocrinol (Oxf)199724239-242en
Aromatase inhibitors continue their ATAC on tamoxifenNicholls H,Trends Mol Med2002812-13en
Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedbackHayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley WF Jr,J Clin Endocrinol Metab2000853027-3035en
Armidex Writing Committee; Investigators Committee Members. Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinomaBonneterre J, Buzard A, Nabholtz JM, Robertson JF, Thurlimann B, von Euler M, Sahmoud T, Webster A, Steinberg M,Cancer2001922247-2258en
Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerabiltiy StudyBonneterre J, Thurlimann B, Robertson JF, Krzakowski M, Mauriac L, Koralewski P, Vergote I, Webster A, Steinberg M, von Euler M,J Clin Oncol2000183748-3757en
Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumorsLigtenberg MJ, Siers M, Themmen AP, Hanselaar TG, Willemsen W, Brunner HG,J Clin Endocrinol Metab1999842233-2234en
An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesionMalchoff CD, Reardon G, MacGillivary DC, Yanase H, Rogol AD, Malchoff DM,J Clin Endocrinol Metab199478803-806en
An animal model of fibrous dysplasiaBianco P, Robey PG,Mol Med Today19995322-323en
An activating Gsa mutation in present in fibrous dyspalsia of bone in the McCune-Albright syndromeShenker A, Weinstein LS, Sweet DE, Spiegel AM,J Clin Endocrinol Metab199479750-755en
Aminohydroxypropylidene-bisphosphonate in the treatment of bone lesions in a case of Gaucher's disease type 3Bembi B, Agosti E, Boehm P, Nassimbeni G, Zanatta M, Vidoni L,Acta Paediatr Scand199483122-124en
Aminohydroxy-propylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patientVarache N, Audran M, Clochon P, Lortholary A, Bouachour G, Alquier P, Basle MF,Clin Rheumatol199110328-332en
Aminohydroxy propylidene bisphosphonate (APD) treatment improves the clinical skeletal manifestaions of Gaucher's dieseaseSamuel R, Katz K, Papapoulos SE, Yosipovitch Z, Zaizov R, Liberman U,Pediatrics199494385-389en
Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomasVallar L, Spada A, Giannattasio G,Nature1987330566-567en
Albright's Hereditary OsteodystrophyL. C. WilsonJournal of Pediatric Endocrinology & Metabolism (JPEM)2006Volume 19, Suppl. 2671-673en
Activating mutations of the stimulatory G protein in the McCune-Albright syndromeWeinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM,N Engl J Med19913251688-1695en
Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumorsFragoso MC, Latronico AC, Carvalho FM, Zerbini MC, Marcondes JA, Araujo LM, Lando VS , Frazzatto ET, Mendonca BB, Villares SM,J Clin Endocrinol Metab1998832074-2078en
Activating mutation of Gs alpha in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytesKim IS, Kim ER, Nam HJ, Chin MO, Moon YH, Oh MR, Yeo UC, Song SM, Kim JS, Uhm MR, Beck NS, Jin DkHorm Res199952235-240en
Activating and inactivating mutations in LH receptorsThemmen AP, Martens JW, Brunner HG,Mol Cell Endocrinol1998145137-142en
Acromegaly and its treatment in the McCune-Albright syndromePremawardhana LDKE, Vora JP, Mills R, Scanalon MF,Clin Endocrinol199236605-608en
Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndromeFoster CM, Ross Jl, Shawker T, Pescovitz OH, Loriaux DL, Cutler GB Jr,J Clin Endocrinol Metab198451161-1165en

Righe 20 di 186
Pagine: [ 1 ] [ 2 ] [ 3 ] [ 4 ] [ 5 ] [ 6 ] [ 7 ] [ 8 ] [  9  ] [ 10 ] 

 


Login:
Password:


Non hai una password?
REGISTRATI

Scordato la password?
Perchè iscriversi?
Consigli di utilizzo


Contatta EAMAS
Associarsi ad EAMAS
Contatta il web master


EAMAS - Associazione Europea amici della Sindrome di McCune-Albright
Via Borgovecchio, 25 - 10041 Carignano (TO) - Italy - Tel:+39 011-9697258 - Fax:+39 011-9697258